Clinical pharmacology of oral gemcitabine in patients with advanced solid tumors

被引：0
|
作者：
Veltkamp, S. A.
Callies, S.
Nol, A.
Visseren-Grul, C. M.
Slapak, C.
Beijnen, J. H.
Schellens, J. H. M.
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2006年 / 62卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：735 / 735
页数：1
相关论文
共 50 条
  • [1] Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors
    Ryan, David P.
    Appleman, Leonard J.
    Lynch, Thomas
    Supko, Jeffrey G.
    Fidias, Panagiotis
    Clark, Jeffrey W.
    Fishman, Mayer
    Zhu, Andrew X.
    Enzinger, Peter C.
    Kashala, Oscar
    Cusack, James, Jr.
    Eder, Joseph P.
    CANCER, 2006, 107 (10) : 2482 - 2489
  • [2] Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors
    Stuurman, F. E.
    Voest, E. E.
    Awada, A.
    Witteveen, P. O.
    Bergeland, T.
    Hals, P. -A.
    Rasch, W.
    Schellens, J. H. M.
    Hendlisz, A.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (04) : 959 - 966
  • [3] Phase I study of oral CP-4126, a gemcitabine analog, in patients with advanced solid tumors
    Hendlisz, A.
    Voest, E. E.
    Schellens, J.
    Awada, A.
    Witteveen, P.
    Stuurman, R.
    Rasch, W.
    Hals, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Phase I study of oral CP-4126, a gemcitabine derivative, in patients with advanced solid tumors
    F. E. Stuurman
    E. E. Voest
    A. Awada
    P. O. Witteveen
    T. Bergeland
    P.-A. Hals
    W. Rasch
    J. H. M. Schellens
    A. Hendlisz
    Investigational New Drugs, 2013, 31 : 959 - 966
  • [5] A phase I clinical study of biweekly pemetrexed and gemcitabine in patients with advanced solid tumors.
    Dudek, A
    Larson, T
    Mellskog, CE
    Bloss, LP
    Obasaju, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 162S - 162S
  • [6] A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors
    Ghalib, Mohammad H.
    Pulla, Mariano Provencio
    Luken, Maria J. De Miguel
    de Juan, Virginia Calvo
    Chaudhary, Imran
    Hammami, M. Bakri
    Vikash, Sindhu
    Maitra, Radhashree
    Martinez, Sara
    Kahatt, Carmen
    Extremera, Sonia
    Fudio, Salvador
    Goel, Sanjay
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (05) : 481 - 491
  • [7] Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors
    Huie, M
    Carducci, M
    Liu, G
    Wilding, GG
    Marnocha, R
    Izquierda, M
    Thomas, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 613 - 617
  • [8] Phase I study on docetaxel and Gemcitabine in patients with advanced solid tumors
    Jaremtchuk, AV
    Zarba, JJ
    Ferro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 138 - 139
  • [9] Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
    Brell, Joanna M.
    Krishnamurthi, Smitha S.
    Rath, Linda
    Bokar, Joseph A.
    Savvides, Panayiotis
    Gibbons, Joseph
    Cooney, Matthew M.
    Meropol, Neal J.
    Ivy, Percy
    Dowlati, Afshin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 547 - 553
  • [10] Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
    Joanna M. Brell
    Smitha S. Krishnamurthi
    Linda Rath
    Joseph A. Bokar
    Panayiotis Savvides
    Joseph Gibbons
    Matthew M. Cooney
    Neal J. Meropol
    Percy Ivy
    Afshin Dowlati
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 547 - 553
12345